These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36569635)

  • 1. Non-pulmonary CFTR-related symptom improvement with ivacaftor in p.Phe508del/p.Arg117His (7T) cystic fibrosis.
    Kuek SL; Massie RJH
    Respirol Case Rep; 2023 Jan; 11(1):e01079. PubMed ID: 36569635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of CFTR-related disorders and cystic fibrosis in an Italian cohort of CRMS/CFSPID subjects in preschool and school age.
    Fevola C; Dolce D; Tosco A; Padoan R; Daccò V; Claut L; Schgor T; Sepe A; Timpano S; Fabrizzi B; Piccinini P; Taccetti G; Bonomi P; Terlizzi V
    Eur J Pediatr; 2024 Feb; 183(2):929-938. PubMed ID: 38054992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A survey of the prevalence, management and outcome of infants with an inconclusive diagnosis following newborn bloodspot screening for cystic fibrosis (CRMS/CFSPID) in six Italian centres.
    Terlizzi V; Claut L; Tosco A; Colombo C; Raia V; Fabrizzi B; Lucarelli M; Angeloni A; Cimino G; Castaldo A; Marsiglio L; Timpano S; Cirilli N; Moroni L; Festini F; Piccinini P; Zavataro L; Bonomi P; Taccetti G; Southern KW; Padoan R
    J Cyst Fibros; 2021 Sep; 20(5):828-834. PubMed ID: 33883100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of CFTR modulators on a cystic fibrosis patient presenting with recurrent pancreatitis in the absence of respiratory symptoms: a case report.
    Johns JD; Rowe SM
    BMC Gastroenterol; 2019 Jul; 19(1):123. PubMed ID: 31296159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cystic fibrosis transmembrane conductance regulator-related metabolic syndrome/cystic fibrosis screen positive, inconclusive diagnosis (CRMS/CFSPID).
    Sinha A; Southern KW
    Breathe (Sheff); 2021 Sep; 17(3):210088. PubMed ID: 35035555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of children with cystic fibrosis screen positive, inconclusive diagnosis/CFTR related metabolic syndrome.
    Gunnett MA; Baker E; Mims C; Self ST; Gutierrez HH; Guimbellot JS
    Front Pediatr; 2023; 11():1127659. PubMed ID: 36969284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystic Fibrosis Transmembrane Conductance Regulator-Related Metabolic Syndrome and Cystic Fibrosis Screen Positive, Inconclusive Diagnosis.
    Ren CL; Borowitz DS; Gonska T; Howenstine MS; Levy H; Massie J; Milla C; Munck A; Southern KW
    J Pediatr; 2017 Feb; 181S():S45-S51.e1. PubMed ID: 28129812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoreactive trypsinogen levels in newborn screened infants with an inconclusive diagnosis of cystic fibrosis.
    Ooi CY; Sutherland R; Castellani C; Keenan K; Boland M; Reisman J; Bjornson C; Chilvers MA; van Wylick R; Kent S; Price A; Mateos-Corral D; Hughes D; Solomon M; Zuberbuhler P; Brusky J; Durie PR; Ratjen F; Gonska T
    BMC Pediatr; 2019 Oct; 19(1):369. PubMed ID: 31640630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different management approaches and outcome for infants with an inconclusive diagnosis following newborn screening for cystic fibrosis (CRMS/CFSPID) and Pseudomonas aeruginosa isolation.
    Dolce D; Claut L; Colombo C; Tosco A; Castaldo A; Padoan R; Timpano S; Fabrizzi B; Bonomi P; Taccetti G; Terlizzi V
    J Cyst Fibros; 2023 Jan; 22(1):73-78. PubMed ID: 35869019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic diagnosis in practice: From cystic fibrosis to CFTR-related disorders.
    Pagin A; Sermet-Gaudelus I; Burgel PR
    Arch Pediatr; 2020 Feb; 27 Suppl 1():eS25-eS29. PubMed ID: 32172933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Updated guidance on the management of children with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome/cystic fibrosis screen positive, inconclusive diagnosis (CRMS/CFSPID).
    Barben J; Castellani C; Munck A; Davies JC; de Winter-de Groot KM; Gartner S; Kashirskaya N; Linnane B; Mayell SJ; McColley S; Ooi CY; Proesmans M; Ren CL; Salinas D; Sands D; Sermet-Gaudelus I; Sommerburg O; Southern KW;
    J Cyst Fibros; 2021 Sep; 20(5):810-819. PubMed ID: 33257262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcomes of a large cohort of individuals with the F508del/5T;TG12 CFTR genotype.
    Tosco A; Castaldo A; Colombo C; Claut L; Carnovale V; Iacotucci P; Lucarelli M; Cimino G; Fabrizzi B; Caporelli N; Majo F; Ciciriello F; Padoan R; Poli P; Taccetti G; Centrone C; Casciaro R; Castellani C; Salvatore D; Colangelo C; Bonomi P; Castaldo G; Terlizzi V
    J Cyst Fibros; 2022 Sep; 21(5):850-855. PubMed ID: 35523714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic spectrum of patients with cystic fibrosis and cystic fibrosis-related disease carrying p.Arg117His.
    Keenan K; Dupuis A; Griffin K; Castellani C; Tullis E; Gonska T
    J Cyst Fibros; 2019 Mar; 18(2):265-270. PubMed ID: 30279124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High rates of anxiety detected in mothers of children with inconclusive cystic fibrosis screening results.
    Ginsburg DK; Salinas DB; Cosanella TM; Wee CP; Saeed MM; Keens TG; Gold JI
    J Cyst Fibros; 2023 May; 22(3):420-426. PubMed ID: 36528525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotype of children with inconclusive cystic fibrosis diagnosis after newborn screening.
    Munck A; Bourmaud A; Bellon G; Picq P; Farrell PM;
    Pediatr Pulmonol; 2020 Apr; 55(4):918-928. PubMed ID: 31916691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Pancreatitis-Associated Protein on Newborn Screening Outcomes and Detection of CFTR-Related Metabolic Syndrome (CRMS)/Cystic Fibrosis Screen Positive, Inconclusive Diagnosis (CFSPID): A Monocentric Prospective Pilot Experience.
    Bianchimani C; Dolce D; Centrone C; Campana S; Ravenni N; Orioli T; Camera E; Mergni G; Fevola C; Bonomi P; Taccetti G; Terlizzi V
    Int J Neonatal Screen; 2022 Aug; 8(3):. PubMed ID: 35997436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inconclusive Diagnosis after Newborn Screening for Cystic Fibrosis.
    Munck A
    Int J Neonatal Screen; 2020 Mar; 6(1):19. PubMed ID: 33073016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term safety and efficacy of tezacaftor-ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND): an open-label extension study.
    Flume PA; Biner RF; Downey DG; Brown C; Jain M; Fischer R; De Boeck K; Sawicki GS; Chang P; Paz-Diaz H; Rubin JL; Yang Y; Hu X; Pasta DJ; Millar SJ; Campbell D; Wang X; Ahluwalia N; Owen CA; Wainwright CE;
    Lancet Respir Med; 2021 Jul; 9(7):733-746. PubMed ID: 33581080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of ivacaftor in late diagnosed cystic fibrosis monozygotic twins heterozygous for F508del and R117H-7T - a case report.
    Welsner M; Straßburg S; Taube C; Sutharsan S
    BMC Pulm Med; 2019 Apr; 19(1):76. PubMed ID: 30975115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cystic fibrosis screen positive, inconclusive diagnosis.
    Barben J; Southern KW
    Curr Opin Pulm Med; 2016 Nov; 22(6):617-22. PubMed ID: 27583671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.